Selective modification of NMR relaxation time in human colorectal carcinoma by using gadolinium-diethylenetriaminepentaacetic acid conjugated with monoclonal antibody 19-9.

Monoclonal antibody 19-9 (mAb 19-9) against human colon adenocarcinoma was conjugated with gadolinium X diethylenetriaminepentaacetic acid (Gd X DTPA) and used as a contrast agent in nuclear magnetic resonance (NMR) in an effort to improve tumor target selectivity in nude mice. The data indicate tha...

Ful tanımlama

Kaydedildi:

Detaylı Bibliyografya
Yayımlandı:	Proc Natl Acad Sci U S A
Asıl Yazarlar:	Curtet, C, Tellier, C, Bohy, J, Conti, M L, Saccavini, J C, Thedrez, P, Douillard, J Y, Chatal, J F, Koprowski, H
Materyal Türü:	Artigo
Dil:	Inglês
Baskı/Yayın Bilgisi:	National Academy of Sciences 1986
Konular:	Research Article
Online Erişim:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC323715/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/3459174/ https://ncbi.nlm.nih.govhttps://doi.org/10.1073/pnas.83.12.4277
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!

Selective modification of NMR relaxation time in human colorectal carcinoma by using gadolinium-diethylenetriaminepentaacetic acid conjugated with monoclonal antibody 19-9.

Benzer Materyaller